| Announce Date | 11/04/2025 |
| EPS Normalized Actual | $5.97 (Miss by $-0.75) |
| EPS GAAP Actual | $5.97 (Miss by $-0.75) |
| Revenue Actual | $1.846B |
| Revenue Surprise | Beat by $1846M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $8.86333 |
| EPS GAAP Estimate | $8.86333 |
| Revenue Estimate | $2.306728571B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 30.6286 | 19.86 | 29.53875 | 32.29962 | 5 |
| Dec 2026 | 25.04668 | 24.29 | 22.29 | 27.64 | 6 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -7.35 | -14.70556 | 1.846B | -2.33% | -276.2M |
| FQ2 2025 (Jun 2025) | 5.44 | -1.44634 | 1.811B | 2.6% | -208.92M |
| FQ1 2025 (Mar 2025) | 1.9 | -0.48524 | 1.353B | 7.54% | -95.42M |
| FQ4 2024 (Dec 2024) | 4.81 | 4.81 | 1.632B | 1.46% | 1632M |
| FQ3 2024 (Sep 2024) | 5.94 | 5.94 | 1.889B | -5.56% | 1889M |
| FQ2 2024 (Jun 2024) | 4.78 | 4.78 | 1.764B | -3.22% | 1764M |
| FQ1 2024 (Mar 2024) | 16.93 | 16.93 | 1.251B | -8.24% | 1251M |
| FQ4 2023 (Dec 2023) | 4.66 | 4.66 | 1.6082B | 8.19% | 1608.2M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
8.86333
Consensus Revenue Estimates
2.306728571B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 6.62735 | -- | 6.38354 | 6.85014 | 7 |
| FQ3 2027 (Sep 2027) | 8.11531 | -- | 7.52113 | 8.50166 | 8 |
| FQ2 2027 (Jun 2027) | 6.17952 | -- | 5.72707 | 6.47371 | 5 |
| FQ1 2027 (Mar 2027) | 2.92915 | -- | 2.82139 | 3.02762 | 7 |
| FQ4 2026 (Dec 2026) | 5.59 | -- | 5.27246 | 5.9418 | 5 |
| FQ3 2026 (Sep 2026) | 7.91 | 192.92 | 7.46067 | 8.40781 | 3 |
| FQ2 2026 (Jun 2026) | 5.69 | 4.39 | 5.36678 | 6.04809 | 3 |
| FQ1 2026 (Mar 2026) | 2.48 | 23.39 | 2.33912 | 2.63608 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.97B | -- | 1.92B | 2.02B | 8 |
| FQ3 2027 (Sep 2027) | 2.23B | -- | 2.1B | 2.31B | 6 |
| FQ2 2027 (Jun 2027) | 2.05B | -- | 1.93B | 2.12B | 6 |
| FQ1 2027 (Mar 2027) | 1.53B | -- | 1.49B | 1.57B | 8 |
| FQ4 2026 (Dec 2026) | 2.32B | -- | 2.22B | 2.43B | 5 |
| FQ3 2026 (Sep 2026) | 2.27B | 18.52 | 2.17B | 2.38B | 4 |
| FQ2 2026 (Jun 2026) | 2.21B | 18.23 | 2.12B | 2.32B | 5 |
| FQ1 2026 (Mar 2026) | 2.16B | 37.51 | 2.07B | 2.27B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 7.35556 | -7.35 | -14.70556 | 200.08% |
| FQ2 2025 (Jun 2025) | 6.88634 | 5.44 | -1.44634 | -26.59% |
| FQ1 2025 (Mar 2025) | 2.38524 | 1.9 | -0.48524 | -25.54% |
| FQ4 2024 (Dec 2024) | 4.81 | 4.81 | 100% | |
| FQ3 2024 (Sep 2024) | 5.94 | 5.94 | 100% | |
| FQ2 2024 (Jun 2024) | 4.78 | 4.78 | 100% | |
| FQ1 2024 (Mar 2024) | 16.93 | 16.93 | 100% | |
| FQ4 2023 (Dec 2023) | 4.66 | 4.66 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $2.12B | $1.85B | $-276.2M | -14.96% |
| FQ2 2025 (Jun 2025) | $2.02B | $1.81B | $-208.92M | -11.54% |
| FQ1 2025 (Mar 2025) | $1.45B | $1.35B | $-95.42M | -7.05% |
| FQ4 2024 (Dec 2024) | $0B | $1.63B | $1632M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.89B | $1889M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.76B | $1764M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.25B | $1251M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.61B | $1608.2M | 100% |